Literature DB >> 27904996

[Methodological approaches in the development of clinical guidelines].

K Albrecht1.   

Abstract

Practical guidelines assist the clinical decision-making process in modern medicine. In rheumatology the number of practical guidelines dealing with diagnostics and therapy of rheumatic diseases is also constantly increasing. Methodological standards for guidelines ensure adequate development under consideration of precisely defined structures. Expert recommendations for action (S1) are distinguished from consensus (S2k) or evidence-based (S2e) as well as consensus and evidence-based (S3) guidelines. Levels of evidence categorize available studies by study design. Parameters for the evaluation of guidelines are summarized in the German instrument for the assessment of guidelines (DELBI).

Entities:  

Keywords:  Diagnostics; Evidence; Quality; Rheumatology; Therapy

Mesh:

Year:  2017        PMID: 27904996     DOI: 10.1007/s00393-016-0238-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  10 in total

1.  [Perspectives in guideline development and implementation in Germany].

Authors:  I B Kopp
Journal:  Z Rheumatol       Date:  2010-06       Impact factor: 1.372

2.  High variability in glucocorticoid starting doses in patients with rheumatoid arthritis: observational data from an early arthritis cohort.

Authors:  Katinka Albrecht; Johanna Callhoff; Matthias Schneider; Angela Zink
Journal:  Rheumatol Int       Date:  2015-02-08       Impact factor: 2.631

3.  Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.

Authors:  A Zink; J Listing; S Ziemer; H Zeidler
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

4.  [German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm].

Authors:  K Krüger; J Wollenhaupt; K Albrecht; R Alten; M Backhaus; C Baerwald; W Bolten; J Braun; H Burkhardt; G Burmester; M Gaubitz; A Gause; E Gromnica-Ihle; H Kellner; J Kuipers; A Krause; H-M Lorenz; B Manger; H Nüßlein; H-G Pott; A Rubbert-Roth; M Schneider; C Specker; H Schulze-Koops; H-P Tony; S Wassenberg; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2012-09       Impact factor: 1.372

5.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 4 Classification and diagnostic criteria].

Authors:  U Kiltz; M Rudwaleit; J Sieper; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

Review 6.  [Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Authors:  U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüßlein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A Tausche; J Braun
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

Review 7.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

Authors:  Josef S Smolen; Robert Landewé; Ferdinand C Breedveld; Maxime Dougados; Paul Emery; Cecile Gaujoux-Viala; Simone Gorter; Rachel Knevel; Jackie Nam; Monika Schoels; Daniel Aletaha; Maya Buch; Laure Gossec; Tom Huizinga; Johannes W J W Bijlsma; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Cem Gabay; Juan Gomez-Reino; Marios Kouloumas; Tore K Kvien; Emilio Martin-Mola; Iain McInnes; Karel Pavelka; Piet van Riel; Marieke Scholte; David L Scott; Tuulikki Sokka; Guido Valesini; Ronald van Vollenhoven; Kevin L Winthrop; John Wong; Angela Zink; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-05-05       Impact factor: 19.103

8.  European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

Authors:  L Gossec; J S Smolen; S Ramiro; M de Wit; M Cutolo; M Dougados; P Emery; R Landewé; S Oliver; D Aletaha; N Betteridge; J Braun; G Burmester; J D Cañete; N Damjanov; O FitzGerald; E Haglund; P Helliwell; T K Kvien; R Lories; T Luger; M Maccarone; H Marzo-Ortega; D McGonagle; I B McInnes; I Olivieri; K Pavelka; G Schett; J Sieper; F van den Bosch; D J Veale; J Wollenhaupt; A Zink; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2015-12-07       Impact factor: 19.103

Review 9.  Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.

Authors:  Christian Dejaco; Yogesh P Singh; Pablo Perel; Andrew Hutchings; Dario Camellino; Sarah Mackie; Eric L Matteson; Bhaskar Dasgupta
Journal:  Ann Rheum Dis       Date:  2015-10       Impact factor: 19.103

10.  A randomized placebo-controlled trial of methotrexate in psoriatic arthritis.

Authors:  Gabrielle H Kingsley; Anna Kowalczyk; Helen Taylor; Fowzia Ibrahim; Jonathan C Packham; Neil J McHugh; Diarmuid M Mulherin; George D Kitas; Kuntal Chakravarty; Brian D M Tom; Aidan G O'Keeffe; Peter J Maddison; David L Scott
Journal:  Rheumatology (Oxford)       Date:  2012-02-17       Impact factor: 7.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.